Publications by authors named "N I Levchenko"
Background: Bronchoplastic resections are now widely used as a surgical treatment for resectable central lung cancer. However, bronchial dehiscence is one of the most life-threatening complications, making it important to identify its risk factors to separate patients who require more attention during the postoperative period.
Methods: The data of 285 patients who underwent bronchoplasty from 2006 to 2021 were retrospectively reviewed.
Discrimination between Complete versus Non-Complete Pathologic Response to Neoadjuvant Therapy Using Ultrasensitive Mutation Analysis: A Proof-of-Concept Study in -Driven Breast Cancer Patients.
Int J Mol Sci
January 2023
Neoadjuvant chemotherapy (NACT) for breast cancer (BC) often results in pathologic complete response (pCR), i.e., the complete elimination of visible cancer cells.
View Article and Find Full Text PDFB Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study.
Front Oncol
June 2022
Article Synopsis
- Triple-negative breast cancer has a poor prognosis and lacks specific treatments, making medications like eribulin crucial for patient care.
- This study identifies key immune markers, such as various types of lymphocytes and their PD1 status, that can help predict how well patients will respond to eribulin.
- Findings indicate that a high ratio of PD1-negative to PD1-positive B cells in tumors correlates with both better short-term treatment response and worse overall survival outcomes in patients with advanced stages of this cancer.
[The status of leukocyte-inhibitory system of inflammation in different age groups of patients with endogenous depression].
Zh Nevrol Psikhiatr Im S S Korsakova
August 2021
Objective: The comparison of inflammatory markers in different age groups of patients with endogenous depression and correlation of immunological parameters with the clinical features of depression.
Material And Methods: The study included 140 patients with endogenous depression (ED) (F21, F31-F34, ICD-10) aged 15 to 82 years (39.8±23 years), including 55 patients of adolescent age (18.